Landoni, Giovanni
Piemonti, Lorenzo
Monforte, Antonella d’Arminio
Grossi, Paolo
Zangrillo, Alberto
Bucci, Enrico
Allegretti, Marcello
Goisis, Giovanni
Gavioli, Elizabeth M.
Patel, Neal
De Pizzol, Maria
Pasedis, Georgea
Mantelli, Flavio
Clinical trials referenced in this document:
Documents that mention this clinical trial
A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia
https://doi.org/10.1007/s40121-022-00644-6
Funding for this research was provided by:
Dompé Farmaceutici SpA
Article History
Received: 18 February 2022
Accepted: 20 April 2022
First Online: 26 May 2022